Adaptive Biotechnologies Corporation - notizie pubblicate 188 - letture 6.150
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Announces IVDR Certification for clonoSEQ® in European Union
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer adaptive biotechnologies corporation p ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer adaptive biotechnologies corporation p ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q2 2024 Earnings Presentation
Second quarter 2024 earnings conference call q2 highlights - fueling growth with strengthened financial profile fueling growth reducing spend ◼ q2 mrd revenue $35.3m ◼ q2 opex ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Quarterly Report for Quarter Ending June 30, 2024 (Form 10-Q)
10-q united states securities and exchange commission washington, dc 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
The text version of this document is not available. you can access the original document here. attachments original link permalink disclaimer adaptive biotechnologies corporation p ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results Form 8 K
Adaptive biotechnologies reports second quarter 2024 financial results seattle, aug. 01, 2024 (globe newswire) - adaptive biotechnologies corporation ("adaptive biotechnologie ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
Pdf version seattle, july 11, 2024 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the gene ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.07 submission of matters to a vote of security holders. on june 7, 2024, adaptive biotechnologies corporation (the "company") held its annual meeting of shareholde ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
Pdf version more than 20 abstracts will be presented from clinical trials and real-world evidence using clonoseq for mrd assessment across multiple types of blood cancers seattle, ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Pdf version seattle, may 29, 2024 (globe newswire) -- adaptive biotechnologies corporation (nasdaq: adpt), a commercial stage biotechnology company that aims to translate the genet ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Additional Proxy Soliciting Materials - Form DEFA14A
Defa14a united states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 filed ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Statement of Changes in Beneficial Ownership - Form 4
Ownership submission form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchang ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
10-q united states securities and exchange commission washington, dc 20549 form 10-q (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Q1 2024 Earnings Presentation
The text version of this document is not available. you can access the original document here. attachments original link original document permalink disclaimer adaptive biotechnolo ...
ADAPTIVE BIOTECHNOLOGIES CORPORATION
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Pdf version seattle, may 07, 2024 (globe newswire) -- adaptive biotechnologies corporation ("adaptive biotechnologies") (nasdaq: adpt), a commercial stage biotechnology c ...
Sei un professionista?
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti